SOLUBLE UNCLOTTABLE COMPLEXES FORMED IN PRESENCE OF FIBRINOGEN DEGRADATION PRODUCTS (FDP) DURING FIBRINOGEN-FIBRIN CONVERSION AND THEIR POTENTIAL SIGNIFICANCE IN PATHOLOGY

被引:167
作者
LIPINSKI, B
WEGRZYNO.Z
BUDZYNSK.AZ
KOPEC, M
LATALLO, ZS
KOWALSKI, E
机构
来源
THROMBOSIS ET DIATHESIS HAEMORRHAGICA | 1967年 / 17卷 / 1-2期
关键词
D O I
10.1055/s-0038-1654112
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
引用
收藏
页码:65 / +
页数:1
相关论文
共 37 条
[11]   PATHOGENESIS OF COAGULATION DEFECT DEVELOPING DURING PATHOLOGICAL PLASMA PROTEOLYTIC (FIBRINOLYTIC) STATES .1. SIGNIFICANCE OF FIBRINOGEN PROTEOLYSIS AND CIRCULATING FIBRINOGEN BREAKDOWN PRODUCTS [J].
FLETCHER, AP ;
SHERRY, S ;
ALKJAERSIG, N .
JOURNAL OF CLINICAL INVESTIGATION, 1962, 41 (04) :896-&
[12]   EFFECT OF FIBRIN AND FIBRINOGEN PROTEOLYSIS PRODUCTS ON CLOT PHYSICAL PROPERTIES [J].
HIRSH, J ;
FLETCHER, AP ;
SHERRY, S .
AMERICAN JOURNAL OF PHYSIOLOGY, 1965, 209 (02) :415-&
[13]  
JERUSHALMY Z, 77 INF EXCH GROUP
[14]   CRYOFIBRINOGENEMIA [J].
KALBFLEISCH, JM ;
BIRD, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 1960, 263 (18) :881-886
[15]  
KEKWICK RA, 1955, BIOCHEM J, V60, P671
[16]  
KESSEL KJ, 1960, VERH DEUTSCH GES INN, V66, P732
[17]  
KOLLER F, 1961, THROMBOS DIATH S1 ED, V6, P166
[18]  
KOPEC M, 1960, THROMB DIATH HAEMOST, V5, P285
[19]  
KOPEC M, IN PRESS
[20]  
KORST DR, 1955, NO TITLE, V10, P945